Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP was delisted on the 13th of August, 2018.
33 hedge funds and large institutions have $19.8M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 6 closing their positions.
143% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 7
18% more capital invested
Capital invested by funds: $16.8M → $19.8M (+$2.99M)
13% less funds holding
Funds holding: 38 → 33 (-5)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MERSOM
Municipal Employees' Retirement System of Michigan
Lansing,
Michigan
|
+$1.06M |
| 2 |
Renaissance Technologies
New York
|
+$412K |
| 3 |
BlackRock
New York
|
+$380K |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
+$246K |
| 5 |
JAM
JW Asset Management
Miami Beach,
Florida
|
+$173K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$330K |
| 2 |
GF
Gabelli Funds
Rye,
New York
|
-$253K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$156K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$112K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$86K |
JNP Hedge Fund Activity: Q2 2017 in Review
33 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Juniper Pharmaceuticals, Inc. Common Stock (JNP) for Q2 2017, worth a combined $19.8M — up 18% from $16.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of JNP and 1 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 17 added.
The largest buyer was Municipal Employees' Retirement System of Michigan, opening a new position worth an estimated $1.06M. The largest seller was Vanguard Group, cutting an estimated $330K.
- 33 institutional investors held Juniper Pharmaceuticals, Inc. Common Stock (JNP) as of Q2 2017, down from 38 in Q1 2017.
- Funds reported $19.8M of Juniper Pharmaceuticals, Inc. Common Stock stock for Q2 2017, up 18% quarter-over-quarter.
- 1 fund opened new Juniper Pharmaceuticals, Inc. Common Stock positions in Q2 2017 and 6 closed out, a net change of -5 holders.
- The largest Juniper Pharmaceuticals, Inc. Common Stock buyer in Q2 2017 was Municipal Employees' Retirement System of Michigan, an estimated $1.06M added.
- The largest Juniper Pharmaceuticals, Inc. Common Stock seller in Q2 2017 was Vanguard Group, an estimated $330K sold.
Based on aggregated 13F filings for Q2 2017.